C12N 2501/117
Keratinocyte growth factors
Official title: Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
C12N2501/117 (Keratinocyte growth factors) appears on 196 US grants and 375 published applications in this corpus.
Search patents in C12N- Granted patents
- 196
- Published applications
- 375
- Assignees
- 153
- Inventors
- 517
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 1 |
| 2002 | 0 | 0 |
| 2003 | 0 | 4 |
| 2004 | 1 | 9 |
| 2005 | 1 | 7 |
| 2006 | 1 | 5 |
| 2007 | 0 | 7 |
| 2008 | 1 | 3 |
| 2009 | 3 | 13 |
| 2010 | 6 | 11 |
| 2011 | 2 | 13 |
| 2012 | 3 | 6 |
| 2013 | 3 | 9 |
| 2014 | 9 | 15 |
| 2015 | 9 | 15 |
| 2016 | 10 | 16 |
| 2017 | 14 | 17 |
| 2018 | 16 | 24 |
| 2019 | 18 | 26 |
| 2020 | 9 | 22 |
| 2021 | 15 | 28 |
| 2022 | 21 | 29 |
| 2023 | 12 | 20 |
| 2024 | 17 | 31 |
| 2025 | 16 | 22 |
| 2026 | 8 | 22 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Ex vivo proliferation of epithelial cells29 Sep 2026US 12,747,425 B2Propagenix Inc.
- Proliferative liver organoid, metabolically activated liver organoid, and use thereof14 Jul 2026US 12,680,080 B2Jsr Corporation
- Biocompatible conditioned cell medium compositions and uses thereof16 Jun 2026US 12,655,384 B2Cellum Biomedical, Inc.
- Stem cell-derived Schwann cells19 May 2026US 12,630,801 B2Memorial Sloan Kettering Cancer Center
- Production of a bioengineered lung28 Apr 2026US 12,612,602 B2Board of Regents, The University of Texas System
- Micropattern-assisted generation of tissue8 Oct 2026US 2026/0308533 A1
- Cryopreserved endocrine cells that express chromogranin a1 Oct 2026US 2026/0294981 A1ViaCyte, Inc.
- Culture media and conditions for in vitro expansion and/or maturation of hepatocytes24 Sep 2026US 2026/0286311 A1Satellite Biosciences, Inc.
- Thymic cell compositions and methods of making3 Sep 2026US 2026/0256842 A1Thymmune Therapeutics, Inc.
- Method for neurological sialadenosis modeling and drug efficacy testing through co-culture of human salivary gland organoids and neurocytomas13 Aug 2026US 2026/0234555 A1
Most cited
By later US patents
- Encapsulation of pancreatic cells derived from human pluripotent stem cells105US 8,278,106 B2ViaCyte, Inc. · 2012
- In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells86US 8,859,286 B2ViaCyte, Inc. · 2014
- Stem cell aggregate suspension compositions and methods of differentiation thereof72US 8,008,075 B2ViaCyte, Inc. · 2011
- Methods of making pancreatic islet cells65US 6,815,203 B1Joslin Diabetes Center, Inc. · 2004
- Culture medium for epithelial stem cells and organoids comprising the stem cells62US 8,642,339 B2Koninklijke Nederlandse Akademie van Wetenschappen · 2014